Angiogenesis
Pharma company initiates phase II clinical study of lung cancer treatment
Published in Cancer Weekly, March 29th, 2005
The trial is designed to evaluate the efficacy of PTK/ZK as a second-line monotherapy in patients with stage IIIB/IV non-small cell lung cancer (NSCLC). The trial, known as the GOAL Study for Growth Arrest with Oral Anti-Angiogenesis in Lung Cancer, will be conducted in France and Germany at five different sites.
This study will include patients with stage IIIB/IV NSCLC who have relapsed or are refractory to first-line therapy.
...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
Source: Cancer Weekly (2005-03-29)
More Articles from Cancer Weekly
- Bladder Cancer
Polymorphism in NF-kappa B binding site linked to higher risk of bladder cancer - Breast Cancer
Compound inhibits critical pathway in breast cancer growth - Breast Cancer
Racial differences in CYP3A5 polymorphisms don't affect tamoxifen metabolism - Colon Cancer
CCSP-2 found to be a novel serological marker of colon neoplasia - Kidney Cancer
No prognostic advantage in quantifying apoptosis factors in Wilms tumors - Abdominal Cancer
Imaging of abdominal cancer lesions facilitated by Tc-99m-bombesin analogue - More from this issue of Cancer Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
